Structure-activity relationships of cannabinoids: a joint CoMFA and pseudoreceptor modelling study

Area of Science:

• Computational Chemistry
• Molecular Modeling
• Pharmacology

Background:

• The CB1 receptor is a key target for cannabinoid-based therapeutics.
• Accurate prediction of ligand binding is crucial for drug discovery.
• Existing models may not fully capture the nuances of CB1 receptor-ligand interactions.

Purpose of the Study:

• To construct a novel cannabinoid pseudoreceptor model for the CB1 receptor.
• To evaluate the predictive performance of the pseudoreceptor model and comparative molecular field analysis (CoMFA) in predicting ligand binding free energy.
• To compare different ligand alignment strategies for CoMFA studies.

Main Methods:

• Construction of a cannabinoid pseudoreceptor model for 31 cannabinoids using YAK molecular modeling software.
• Two CoMFA studies were performed: one before pseudoreceptor construction and one using ligand alignment from the final pseudoreceptor model.
• Evaluation of cross-validated r2 values and predictive ability of the models.

Main Results:

• The pseudoreceptor model and CoMFA studies demonstrated good predictive capabilities for cannabinoid binding free energy.
• Ligand alignment derived from the pseudoreceptor model yielded improved cross-validated r2 values (0.79) compared to initial superposition (0.63).
• Pharmacophore alignment from the pseudoreceptor model showed superior predictive ability.

Conclusions:

• The developed cannabinoid pseudoreceptor model is a valuable tool for understanding CB1 receptor-ligand interactions.
• Integrating pseudoreceptor models with CoMFA enhances the accuracy of predicting ligand binding free energy.
• The study highlights the importance of optimized ligand alignment in QSAR studies.